On the article "Drugs targeting protease- activated receptor-4 improve the anti-thrombotic therapeutic window"

被引：1

作者：

Wong, Pancras C. ^{[1
]}

Yang, Jing ^{[1
]}

机构：

[1] Bristol Myers Squibb Co, Pennington, NJ 08534 USA

来源：

ANNALS OF TRANSLATIONAL MEDICINE | 2018年 / 6卷 / 03期

关键词：

D O I：

10.21037/atm.2017.11.31

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：2

共 5 条

[1] Drugs targeting protease-activated receptor-4 improve the anti-thrombotic therapeutic window
French, Shauna L.
Hamilton, Justin R.
ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (23)
[2] Differential anti-thrombotic benefit and bleeding risk profiles of antagonists of protease-activated receptor 1 and 4 in Cynomolgus Macaques
Wickham, L. Alexandra
Sitko, Gary
Stranieri-Michener, Maria
Handt, Larry
Basso, Andrea
Fried, Steven
Chu, Lin
Maderia, Maria
Owens, Karen
Castriota, Gino
Chen, Zhu
Metzger, Joseph M.
Imbriglio, Jason
Wang, Xinkang
Cai, Tian-Quan
THROMBOSIS RESEARCH, 2016, 145 : 133 - 139
[3] The platelet protease- activated receptor-4 antagonist, UDM-002555, alone and in combination with aspirin inhibits arterial thrombosis with limited impact on hemostasis in cynomolgus monkeys
Wong, P.
Watson, C.
Bostwick, J.
Banville, J.
Wexler, R.
Priestley, E.
Marinier, A.
Bouvier, M.
Seiffert, D.
Schumacher, W.
Yang, J.
EUROPEAN HEART JOURNAL, 2016, 37 : 1017 - 1017
[4] Anti-thrombotic and bleeding time effects of E5555, an orally active protease-activated receptor-1 antagonist, in guinea pigs
Kogushi, M
Kobayashi, H
Matsuoka, T
Suzuki, S
Kawahara, T
Kajiwara, A
Hishinuma, L
CIRCULATION, 2003, 108 (17) : 280 - 280
[5] Favorable therapeutic index of an orally-active small-molecule antagonist of the platelet protease-activated receptor-4, BMS-986141, compared with the P2Y12 antagonist ticagrelor in cynomolgus monkeys
Wong, P.
Banville, J.
Wexler, R.
Priestley, E.
Marinier, A.
Bouvier, M.
Gordon, D.
Yang, J.
EUROPEAN HEART JOURNAL, 2020, 41 : 3380 - 3380

← 1 →